RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions

B. J. Collins, G. Chiappetta, A. B. Schneider, M. Santoro, F. Pentimalli, L. Fogelfeld, T. Gierlowski, E. Shore-Freedman, G. Jaffe, A. Fusco

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Both external and internal exposure to radiation have been linked to the development of papillary thyroid cancer. Rearrangement of the gene for RET tyrosine kinase and subsequent expression of this protein has also been found to occur in many papillary thyroid cancers, and with increased frequency in radiation-related cancers following the Chernobyl accident. However, little has been reported on the frequency of RET rearrangements in cancers after exposure to external radiation. We here report on RET protein immunoreactivity in paraffin-embedded thyroid samples from 30 patients with papillary thyroid cancer who received radiation treatment during childhood for benign conditions at Michael Reese Hospital in Chicago, and in 34 patients identified from the tumor registry as having papillary thyroid cancer with no history of therapeutic radiation. The subjects were characterized by sex, age at surgery, and the following attributes of tumor pathology: size, number of lobes involved, number of foci, lymph node metastases, and soft tissue invasion. Representative tissue samples were reacted with an antibody against the RET tyrosine kinase domain whose expression has been shown to correlate highly with RET/PTC rearrangements. A greater percentage of cancers positive for RET immunoreactivity was found in the radiation-exposed group (86.7% vs. 52.9%, P = 0.006). Although the mean age at surgery of the exposed group was lower than the control group, there was no correlation of positive RET immunoreactivity with the age at surgery. No characteristics of the tumors were associated with positive RET immunoreactivity. In summary, the greater incidence of RET-immunopositives in the irradiated group indicates that the expression of RET immunoreactivity is strongly associated with radiation exposure, but the prognostic significance of this is not yet clear.

Original languageEnglish
Pages (from-to)3941-3946
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume87
Issue number8
DOIs
Publication statusPublished - 2002

Fingerprint

Radiation
Neoplasms
Surgery
Tumors
Protein-Tyrosine Kinases
Factor IX
Tissue
Gene Rearrangement
Paraffin
Pathology
Accidents
Registries
Papillary Thyroid cancer
Thyroid Gland
Proteins
Lymph Nodes
Neoplasm Metastasis
Genes
Control Groups
Antibodies

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Collins, B. J., Chiappetta, G., Schneider, A. B., Santoro, M., Pentimalli, F., Fogelfeld, L., ... Fusco, A. (2002). RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. Journal of Clinical Endocrinology and Metabolism, 87(8), 3941-3946. https://doi.org/10.1210/jc.87.8.3941

RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. / Collins, B. J.; Chiappetta, G.; Schneider, A. B.; Santoro, M.; Pentimalli, F.; Fogelfeld, L.; Gierlowski, T.; Shore-Freedman, E.; Jaffe, G.; Fusco, A.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 87, No. 8, 2002, p. 3941-3946.

Research output: Contribution to journalArticle

Collins, BJ, Chiappetta, G, Schneider, AB, Santoro, M, Pentimalli, F, Fogelfeld, L, Gierlowski, T, Shore-Freedman, E, Jaffe, G & Fusco, A 2002, 'RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions', Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 8, pp. 3941-3946. https://doi.org/10.1210/jc.87.8.3941
Collins, B. J. ; Chiappetta, G. ; Schneider, A. B. ; Santoro, M. ; Pentimalli, F. ; Fogelfeld, L. ; Gierlowski, T. ; Shore-Freedman, E. ; Jaffe, G. ; Fusco, A. / RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. In: Journal of Clinical Endocrinology and Metabolism. 2002 ; Vol. 87, No. 8. pp. 3941-3946.
@article{1f51d65345fe43a18a2e6ae86c1660fe,
title = "RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions",
abstract = "Both external and internal exposure to radiation have been linked to the development of papillary thyroid cancer. Rearrangement of the gene for RET tyrosine kinase and subsequent expression of this protein has also been found to occur in many papillary thyroid cancers, and with increased frequency in radiation-related cancers following the Chernobyl accident. However, little has been reported on the frequency of RET rearrangements in cancers after exposure to external radiation. We here report on RET protein immunoreactivity in paraffin-embedded thyroid samples from 30 patients with papillary thyroid cancer who received radiation treatment during childhood for benign conditions at Michael Reese Hospital in Chicago, and in 34 patients identified from the tumor registry as having papillary thyroid cancer with no history of therapeutic radiation. The subjects were characterized by sex, age at surgery, and the following attributes of tumor pathology: size, number of lobes involved, number of foci, lymph node metastases, and soft tissue invasion. Representative tissue samples were reacted with an antibody against the RET tyrosine kinase domain whose expression has been shown to correlate highly with RET/PTC rearrangements. A greater percentage of cancers positive for RET immunoreactivity was found in the radiation-exposed group (86.7{\%} vs. 52.9{\%}, P = 0.006). Although the mean age at surgery of the exposed group was lower than the control group, there was no correlation of positive RET immunoreactivity with the age at surgery. No characteristics of the tumors were associated with positive RET immunoreactivity. In summary, the greater incidence of RET-immunopositives in the irradiated group indicates that the expression of RET immunoreactivity is strongly associated with radiation exposure, but the prognostic significance of this is not yet clear.",
author = "Collins, {B. J.} and G. Chiappetta and Schneider, {A. B.} and M. Santoro and F. Pentimalli and L. Fogelfeld and T. Gierlowski and E. Shore-Freedman and G. Jaffe and A. Fusco",
year = "2002",
doi = "10.1210/jc.87.8.3941",
language = "English",
volume = "87",
pages = "3941--3946",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions

AU - Collins, B. J.

AU - Chiappetta, G.

AU - Schneider, A. B.

AU - Santoro, M.

AU - Pentimalli, F.

AU - Fogelfeld, L.

AU - Gierlowski, T.

AU - Shore-Freedman, E.

AU - Jaffe, G.

AU - Fusco, A.

PY - 2002

Y1 - 2002

N2 - Both external and internal exposure to radiation have been linked to the development of papillary thyroid cancer. Rearrangement of the gene for RET tyrosine kinase and subsequent expression of this protein has also been found to occur in many papillary thyroid cancers, and with increased frequency in radiation-related cancers following the Chernobyl accident. However, little has been reported on the frequency of RET rearrangements in cancers after exposure to external radiation. We here report on RET protein immunoreactivity in paraffin-embedded thyroid samples from 30 patients with papillary thyroid cancer who received radiation treatment during childhood for benign conditions at Michael Reese Hospital in Chicago, and in 34 patients identified from the tumor registry as having papillary thyroid cancer with no history of therapeutic radiation. The subjects were characterized by sex, age at surgery, and the following attributes of tumor pathology: size, number of lobes involved, number of foci, lymph node metastases, and soft tissue invasion. Representative tissue samples were reacted with an antibody against the RET tyrosine kinase domain whose expression has been shown to correlate highly with RET/PTC rearrangements. A greater percentage of cancers positive for RET immunoreactivity was found in the radiation-exposed group (86.7% vs. 52.9%, P = 0.006). Although the mean age at surgery of the exposed group was lower than the control group, there was no correlation of positive RET immunoreactivity with the age at surgery. No characteristics of the tumors were associated with positive RET immunoreactivity. In summary, the greater incidence of RET-immunopositives in the irradiated group indicates that the expression of RET immunoreactivity is strongly associated with radiation exposure, but the prognostic significance of this is not yet clear.

AB - Both external and internal exposure to radiation have been linked to the development of papillary thyroid cancer. Rearrangement of the gene for RET tyrosine kinase and subsequent expression of this protein has also been found to occur in many papillary thyroid cancers, and with increased frequency in radiation-related cancers following the Chernobyl accident. However, little has been reported on the frequency of RET rearrangements in cancers after exposure to external radiation. We here report on RET protein immunoreactivity in paraffin-embedded thyroid samples from 30 patients with papillary thyroid cancer who received radiation treatment during childhood for benign conditions at Michael Reese Hospital in Chicago, and in 34 patients identified from the tumor registry as having papillary thyroid cancer with no history of therapeutic radiation. The subjects were characterized by sex, age at surgery, and the following attributes of tumor pathology: size, number of lobes involved, number of foci, lymph node metastases, and soft tissue invasion. Representative tissue samples were reacted with an antibody against the RET tyrosine kinase domain whose expression has been shown to correlate highly with RET/PTC rearrangements. A greater percentage of cancers positive for RET immunoreactivity was found in the radiation-exposed group (86.7% vs. 52.9%, P = 0.006). Although the mean age at surgery of the exposed group was lower than the control group, there was no correlation of positive RET immunoreactivity with the age at surgery. No characteristics of the tumors were associated with positive RET immunoreactivity. In summary, the greater incidence of RET-immunopositives in the irradiated group indicates that the expression of RET immunoreactivity is strongly associated with radiation exposure, but the prognostic significance of this is not yet clear.

UR - http://www.scopus.com/inward/record.url?scp=18544375569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18544375569&partnerID=8YFLogxK

U2 - 10.1210/jc.87.8.3941

DO - 10.1210/jc.87.8.3941

M3 - Article

C2 - 12161537

AN - SCOPUS:18544375569

VL - 87

SP - 3941

EP - 3946

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 8

ER -